| Mr Mark James Walker, FNP-C | |
|
75 Francis St, Boston, MA 02115-6110 | |
| (617) 732-5000 | |
| Not Available |
| Full Name | Mr Mark James Walker |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 75 Francis St, Boston, Massachusetts |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003330028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN279876 (Massachusetts) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | RN279876 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
Since recent medical findings have revealed that some families have increased breast cancer risk, a number of people are turning to cancer genetic services to learn more.
Alere Health, LLC, a leading provider of personal health support solutions to employers and health plans, announced today that it will introduce its new global logo and brand identity at AHIP's Institute 2010 in Las Vegas, June 9-11. The rollout of the new brand identity is part of a global campaign by its parent company, Inverness Medical Innovations, Inc., a global leader in rapid point-of-care diagnostics, to align the majority of its operations under the single brand, Alere.
Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
› Verified 4 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
Since recent medical findings have revealed that some families have increased breast cancer risk, a number of people are turning to cancer genetic services to learn more.
Alere Health, LLC, a leading provider of personal health support solutions to employers and health plans, announced today that it will introduce its new global logo and brand identity at AHIP's Institute 2010 in Las Vegas, June 9-11. The rollout of the new brand identity is part of a global campaign by its parent company, Inverness Medical Innovations, Inc., a global leader in rapid point-of-care diagnostics, to align the majority of its operations under the single brand, Alere.
Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
› Verified 4 days ago
| Entity Name | Mass General Brigham Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720486830 PECOS PAC ID: 9436470119 Enrollment ID: O20150605002309 |
News Archive
Since recent medical findings have revealed that some families have increased breast cancer risk, a number of people are turning to cancer genetic services to learn more.
Alere Health, LLC, a leading provider of personal health support solutions to employers and health plans, announced today that it will introduce its new global logo and brand identity at AHIP's Institute 2010 in Las Vegas, June 9-11. The rollout of the new brand identity is part of a global campaign by its parent company, Inverness Medical Innovations, Inc., a global leader in rapid point-of-care diagnostics, to align the majority of its operations under the single brand, Alere.
Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Mark James Walker, FNP-C 75 Francis St, Boston, MA 02115-6110 Ph: () - | Mr Mark James Walker, FNP-C 75 Francis St, Boston, MA 02115-6110 Ph: (617) 732-5000 |
News Archive
Since recent medical findings have revealed that some families have increased breast cancer risk, a number of people are turning to cancer genetic services to learn more.
Alere Health, LLC, a leading provider of personal health support solutions to employers and health plans, announced today that it will introduce its new global logo and brand identity at AHIP's Institute 2010 in Las Vegas, June 9-11. The rollout of the new brand identity is part of a global campaign by its parent company, Inverness Medical Innovations, Inc., a global leader in rapid point-of-care diagnostics, to align the majority of its operations under the single brand, Alere.
Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.
Angeles suffers from a severe and rare genetic disease called Acute Intermittent Porphyria (AIP). This means, one of her genes restrains her liver to produce a specific protein needed for the metabolism of the blood. During an AIP attack Angeles usually feels intense abdominal pain, and her mental status changes. Women live at an increased risk to trigger the symptoms, because porphyria is related to the menstrual cycle.
Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.
› Verified 4 days ago
Kristen Cahill, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Washington St, Boston, MA 02111 Phone: 508-685-8452 | |
Mrs. Patricia Noreen Finneran, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15 Parkman St, Wac 440, Boston, MA 02114 Phone: 617-643-4709 | |
Miss Megan Elizabeth Smetana, RN, CPNP-AC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Cardiology, Boston, MA 02115 Phone: 617-355-8689 | |
Mr. Courtney Sullivan Fratto, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Hunnewell Building 322, Boston, MA 02115 Phone: 857-218-4085 | |
Ms. Kelly Elisha Trecartin, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 55 Fruit St, Bigalow 852 F, Boston, MA 02114 Phone: 617-726-7400 Fax: 617-726-4149 | |
Mrs. Melissa Ashley Ziogas, APRN-FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-1000 | |
Jamie Marie Allen, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4410 |